Connection

Andrew Jakymiw to Autoantigens

This is a "connection" page, showing publications Andrew Jakymiw has written about Autoantigens.
Connection Strength

1.378
  1. Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. J Control Release. 2015 Nov 28; 218:72-81.
    View in: PubMed
    Score: 0.490
  2. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells. PLoS One. 2013; 8(9):e73348.
    View in: PubMed
    Score: 0.426
  3. Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol. 2005 Dec; 7(12):1267-74.
    View in: PubMed
    Score: 0.248
  4. CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther. 2010 Oct 01; 10(7):694-9.
    View in: PubMed
    Score: 0.087
  5. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J Cell Sci. 2004 Nov 01; 117(Pt 23):5567-78.
    View in: PubMed
    Score: 0.058
  6. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA. 2003 Oct; 9(10):1171-3.
    View in: PubMed
    Score: 0.053
  7. GW bodies, microRNAs and the cell cycle. Cell Cycle. 2006 Feb; 5(3):242-5.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.